Insiders · Profile

Chadwick Jeremy G

Chief Operating Officer at Kymera Therapeutics · Sr. VP, Pgm Mgmt and Clin Ops at MADRIGAL PHARMACEUTICALS. Filing since 5 Jan 2009. CIK 0001388406

Company
Date
Role
Action
Shares
Amount
Of holding
27 May 2026
Chief Operating Officer
Sold on a plan
4,279
$349.10K
8.9%
26 May 2026
Chief Operating Officer
Sold on a plan
12,905
$1.02M
21.1%
22 Apr 2026
Chief Operating Officer
Sold on a plan
300
$27.00K
0.5%
15 Apr 2026
Chief Operating Officer
Sold on a plan
1,300
$117.00K
2.1%
14 Apr 2026
Chief Operating Officer
Sold on a plan
5,251
$472.60K
7.9%
1 Apr 2026
Chief Operating Officer
Sold on a plan
14,640
$1.25M
19.3%
31 Mar 2026
Chief Operating Officer
Sold on a plan
7,600
$648.88K
11.0%
25 Mar 2026
Chief Operating Officer
Sold on a plan
24,727
$1.98M
28.8%
23 Mar 2026
Chief Operating Officer
Sold on a plan
91,250
$7.06M
59.9%
11 Mar 2026
Chief Operating Officer
Sold on a plan
25,758
$2.15M
27.5%
4 Mar 2026
Chief Operating Officer
Sold at will
3,919
$334.27K
5.0%
2 Mar 2026
Chief Operating Officer
Sold at will
2,039
$181.32K
2.6%
23 May 2025
Chief Operating Officer
Sold at will
2,575
$75.44K
3.7%
3 Mar 2025
Chief Operating Officer
Sold at will
1,383
$42.11K
2.0%
23 May 2024
Chief Operating Officer
Sold at will
2,575
$90.10K
5.5%
5 Jan 2009
Sr. VP, Pgm Mgmt and Clin Ops
Sold, plan not stated
4,573
$28.38K
22.4%
16 decisions on file.